EFPIA: Sustainability Statement
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has published details of what its members are doing to improve the environmental sustainability of the pharma industry. EFPIA aims to adopt innovative practices that reduce environmental impact, exceeding EU Green Deal targets under the Zero Pollution, Circular Economy, and Climate Action plans.
Key commitments include:
- Carbon Reduction Targets: Setting and externally verifying science-based targets to reduce greenhouse gase (GHG) emissions across operations and value chains, aligned with the Paris Agreement.
- Renewable Energy and Clean Technology: Improving energy efficiency and prioritising renewable energy sources for facilities, including on-site generation and off-site projects.
- Advancing Circularity: Enhancing resource efficiency, optimising manufacturing and supply chains, improving waste management, and implementing sustainable packaging.
- Collaboration and Knowledge Sharing: Collaborating with stakeholders, sharing best practices, and facilitating industry-wide initiatives for innovation in decarbonization.
- Pharmaceuticals in the Environment: Actively addressing environmental risks of pharmaceuticals, enhancing detection processes, and reducing discharges from manufacturing plants.
Source:
EFPIA: News & Events
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
